Geneva – On the anniversary of the Solidarity Call to Action and the establishment of the C-TAP initiative, the Medicines Patent Pool (MPP) reaffirms its commitment and support to C-TAP by offering its expertise in licensing, to ensure that no one, wherever they live, are left behind when it comes to access to COVID-19 health technologies. The last year has seen an unprecedented response in developing tools to fight COVID-19. Today, there is still much to be done to ensure equitable access to COVID-19 health technologies, and C-TAP has a pivotal role in addressing challenges in global manufacturing and supply, along with universal access. MPP welcomes the growing support from partners for this very much needed initiative.

> Special press conference to mark the first anniversary of the COVID-19 Technology Access Pool

More on C-TAP